Jump to ContentJump to Main Navigation
Show Summary Details

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board Member: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Sies, Helmut / Turk, Boris / Wittinghofer, Alfred

12 Issues per year

IMPACT FACTOR 2015: 2.710
Rank 142 out of 289 in category Biochemistry & Molecular Biology in the 2015 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 1.607
Source Normalized Impact per Paper (SNIP) 2015: 0.751
Impact per Publication (IPP) 2015: 2.609

See all formats and pricing
Volume 389, Issue 7 (Jul 2008)


Adult progenitor cells in vascular remodeling during atherosclerosis

Mihail Hristov
  • 1Institut für Molekulare Herz-Kreislaufforschung (IMCAR), Universitätsklinikum der RWTH Aachen, Pauwelsstrasse 30, D-52074 Aachen, Germany and IZKF ‘BIOMAT’, Universitätsklinikum der RWTH Aachen, Pauwelsstrasse 30, D-52074 Aachen, Germany
/ Alma Zernecke
  • 2Institut für Molekulare Herz-Kreislaufforschung (IMCAR), Universitätsklinikum der RWTH Aachen, Pauwelsstrasse 30, D-52074 Aachen, Germany
/ Andreas Schober
  • 3Abteilung Kardiologie, Medizinische Poliklinik, Klinikum der LMU München, Pettenkoferstrasse 8a, D-80336 München, Germany
/ Christian Weber
  • 4Institut für Molekulare Herz-Kreislaufforschung (IMCAR), Universitätsklinikum der RWTH Aachen, Pauwelsstrasse 30, D-52074 Aachen, Germany
Published Online: 2008-06-06 | DOI: https://doi.org/10.1515/BC.2008.093


The mobilization and recruitment of bone marrow-derived, circulating or tissue resident progenitor cells giving rise to smooth muscle-like cells have been implicated in neointima hyperplasia after arterial injury and in accelerated forms of arterial lesion formation, e.g., transplant arteriopathy or graft vasculopathy. By contrast, convincing evidence has emerged that the vascular homing of endothelial progenitor cells (EPCs) contributes to endothelial recovery, thus limiting neointima formation after arterial injury. In the chronic context of primary atherosclerosis, plaque progression and destabilization, a more complex picture has become apparent. In patients with coronary artery disease, the number and function of EPCs have been linked with an improved endothelial function or regeneration, but have been inversely correlated with cardiovascular risk. In animal models, however, the injection of bone marrow cells or EPCs, or the application of stem-cell mobilizing factors, have been associated with an exacerbation of atherosclerosis and unstable plaque phenotypes, whereas the contribution of bone marrow-derived smooth muscle progenitors to primary atherosclerosis appears to be rather confined. Here, we discuss crucial biochemical cues, namelychemokines, adhesion molecules, growth factors and pharmacological means that guide and control the context-specific mobilization, recruitment and fate of vascular progenitor cells in arterial remodeling during atherosclerosis.

Keywords: arterial disease; chemokines; myocardial infarction; stem cells

About the article

Corresponding author

Published Online: 2008-06-06

Published in Print: 2008-07-01

Citation Information: Biological Chemistry, ISSN (Online) 1437-4315, ISSN (Print) 1431-6730, DOI: https://doi.org/10.1515/BC.2008.093. Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Alyne Souza Felix, Nemesis Monteiro, Vinícius Novaes Rocha, Genilza Oliveira, Ana Lucia Nascimento, Laís de Carvalho, Alessandra Thole, and Jorge Carvalho
Biochemistry and Cell Biology, 2015, Page 1
L. De Toni, A. Di Nisio, S. Magagna, A. Michielan, M. Martinato, G. C. Sturniolo, R. D’Incà, C. Foresta, and A. Garolla
Gastroenterology Research and Practice, 2015, Volume 2015, Page 1
G. Togliatto, A. Trombetta, P. Dentelli, A. Baragli, A. Rosso, R. Granata, D. Ghigo, L. Pegoraro, E. Ghigo, and M. F. Brizzi
Diabetes, 2010, Volume 59, Number 4, Page 1016
Giris Jacob and Yoram Vardi
European Urology, 2009, Volume 55, Number 4, Page 797
Samuel Morris-Rosenfeld, Erwin Blessing, Michael R. Preusch, Claudia Albrecht, Angelika Bierhaus, Martin Andrassy, Peter P. Nawroth, Michael E. Rosenfeld, Hugo A. Katus, and Florian Bea
European Journal of Clinical Investigation, 2011, Volume 41, Number 11, Page 1164
Yuri V. Bobryshev, Dinh Tran, Natalia K. Botelho, Reginald V.N. Lord, and Alexander N. Orekhov
Atherosclerosis, 2011, Volume 215, Number 2, Page 355
Jennifer L. Olson, Anthony Atala, and James J. Yoo
Chonnam Medical Journal, 2011, Volume 47, Number 1, Page 1
Fa-Ming Chen, Li-An Wu, Min Zhang, Rong Zhang, and Hai-Hua Sun
Biomaterials, 2011, Volume 32, Number 12, Page 3189
Yuly Sánchez-Hernández, Umberto Laforenza, Elisa Bonetti, Jacopo Fontana, Silvia Dragoni, Marika Russo, José Everardo Avelino-Cruz, Sergio Schinelli, Domenico Testa, Germano Guerra, Vittorio Rosti, Franco Tanzi, and Francesco Moccia
Stem Cells and Development, 2010, Volume 19, Number 12, Page 1967
Mincai Li, Jun Yu, Yan Li, Dujuan Li, Dan Yan, and Qiurong Ruan
Cellular Reprogramming (Formerly "Cloning and Stem Cells"), 2010, Volume 12, Number 4, Page 405
A. Atala
British Medical Bulletin, 2011, Volume 97, Number 1, Page 81
A. Schober, M. Hristov, S. Kofler, R. Forbrig, B. Lohr, N. Heussen, Z. Zhe, S. Akhtar, U. Schumann, F. Krotz, M. Leibig, A. Konig, I. Kaczmarek, B. Reichart, V. Klauss, C. Weber, and H.-Y. Sohn
European Heart Journal, 2011, Volume 32, Number 4, Page 476
Xiao Li Deng, Xiao Xia Li, Xiang Yuan Liu, Lin Sun, and Rui Liu
Rheumatology International, 2010, Volume 30, Number 11, Page 1429
Athanasios Didangelos, David Simper, Claudia Monaco, and Manuel Mayr
Current Atherosclerosis Reports, 2009, Volume 11, Number 3, Page 188
Tamer Aboushwareb and Anthony Atala
Nature Clinical Practice Urology, 2008, Volume 5, Number 11, Page 621

Comments (0)

Please log in or register to comment.
Log in